Zsolt Illes

24PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyRegenerative medicine (incl. stem cells)Predictive and prognostic markersCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

|Mar 28, 2026
[Developing anti-CD20 molecules and B cell depletion in multiple sclerosis].

Zsolt Illés

|Aug 29, 2025
Phenotypic Changes in a Monocyte Cluster with High Interleukin-1 Beta Expression during Long-Term Anti-CD20 Therapy.

Mie Waede, Christina Kingo, Karina Damsbo

|Dec 23, 2024
Patterns and predictors of multiple sclerosis phenotype transition.

Luigi Pontieri, Nupur Greene, Malthe Faurschou Wandall-Holm

|Sep 16, 2024
Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti-CD20 therapy.

Mie Waede, Lasse F Voss, Christina Kingo

|Aug 29, 2024
Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis.

Zsofia Kakucs, Zsolt Illes, Zsofia Hayden

Pageof 4

Frequent Collaborators

4 joint publications

Tobias Sejbaek

4 joint publications

Melinda Magyari

3 joint publications

Maria L Elkjaer

2 joint publications

Jakob Schäfer